These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26446398)

  • 1. Highly informative marker sets consisting of genes with low individual degree of differential expression.
    Galatenko VV; Shkurnikov MY; Samatov TR; Galatenko AV; Mityakina IA; Kaprin AD; Schumacher U; Tonevitsky AG
    Sci Rep; 2015 Oct; 5():14967. PubMed ID: 26446398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
    Xu G; Zhang M; Zhu H; Xu J
    Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verifying the markers of ovarian cancer using RNA-seq data.
    Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
    Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
    Sundaramurthy G; Eghbalnia HR
    Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
    Garrido-Castro AC; Winer EP
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376163
    [No Abstract]   [Full Text] [Related]  

  • 8. Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer.
    Teschendorff AE; Li L; Yang Z
    Genome Biol; 2015 Apr; 16(1):61. PubMed ID: 25886003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer.
    Pavlou MP; Dimitromanolakis A; Martinez-Morillo E; Smid M; Foekens JA; Diamandis EP
    J Proteome Res; 2014 Jun; 13(6):2897-909. PubMed ID: 24799281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
    Yang F; Foekens JA; Yu J; Sieuwerts AM; Timmermans M; Klijn JG; Atkins D; Wang Y; Jiang Y
    Oncogene; 2006 Mar; 25(9):1413-9. PubMed ID: 16261164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
    Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
    Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signatures of estrogen receptor-associated genes in breast cancer predict clinical outcome.
    Wittliff JL; Kruer TL; Andres SA; Smolenkova I
    Adv Exp Med Biol; 2008; 617():349-57. PubMed ID: 18497058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy.
    Enewold L; Geiger AM; Zujewski J; Harlan LC
    Breast Cancer Res Treat; 2015 May; 151(1):149-56. PubMed ID: 25859924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.
    Schneider J; Ruschhaupt M; Buness A; Asslaber M; Regitnig P; Zatloukal K; Schippinger W; Ploner F; Poustka A; Sültmann H
    Int J Cancer; 2006 Dec; 119(12):2974-9. PubMed ID: 17019712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
    Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
    J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGMD: A novel approach for functional gene module detection in cancer.
    Jin D; Lee H
    PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis.
    Germano S; Kennedy S; Rani S; Gleeson G; Clynes M; Doolan P; McDonnell S; Hughes L; Crown J; O'Driscoll L
    Int J Cancer; 2012 May; 130(9):1991-2002. PubMed ID: 21618523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.
    Rozenchan PB; Carraro DM; Brentani H; de Carvalho Mota LD; Bastos EP; e Ferreira EN; Torres CH; Katayama ML; Roela RA; Lyra EC; Soares FA; Folgueira MA; Góes JC; Brentani MM
    Int J Cancer; 2009 Dec; 125(12):2767-77. PubMed ID: 19530251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.
    Győrffy B; Benke Z; Lánczky A; Balázs B; Szállási Z; Timár J; Schäfer R
    Breast Cancer Res Treat; 2012 Apr; 132(3):1025-34. PubMed ID: 21773767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable Gene Signature Selection for Prediction of Breast Cancer Recurrence Using Joint Mutual Information.
    Sehhati M; Mehridehnavi A; Rabbani H; Pourhossein M
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1440-8. PubMed ID: 26671813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.